文献速递主动脉疾病

择期腹主动脉瘤腔内修复术后一个月监测CT扫描的价值有限

There Is Limited Value in the One Month Post Endovascular Aortic Aneurysm Repair Surveillance Computed Tomography Scan.
PubMed 文献 · Ann Vasc Surg · 2018-09-22

该单中心回顾性研究分析了12年间363例择期EVAR患者,评估术后1个月CTA的效用。1个月CTA组316例中检出98例(31%)内漏,仅5例(1.5%)需干预;结论认为对符合器械说明书且术中完成造影无I型内漏的患者,1个月CTA价值有限,6个月开始常规监测是安全的。

要点

  • 1个月CTA组316例中检出98例(31%)内漏,仅5例(1.5%)需干预。
  • 158例有1个月和3个月CTA的患者中,47例内漏持续,9例新检出,13例消退。
  • 47例仅6个月CTA的患者中,16例内漏为完成造影未发现,2例需再干预。

核心结论

  • 对符合器械说明书且术中完成造影无I型内漏的择期EVAR患者,1个月监测CTA价值有限。
  • 在该患者人群中,6个月开始常规EVAR监测是安全的。

研究设计与样本

  • 单中心回顾性病历回顾,纳入12年间在某三级医疗中心接受择期EVAR且有术后监测影像的患者。
  • 共363例患者接受择期EVAR并有可用术后影像;排除无术后监测影像者。

主要发现

  • 1个月随访CTA组316例中检出98例(31%)内漏,其中5例(1.5%)需干预:1例为髂支内折,4例为I型内漏(3例为说明书外使用患者,1例为术中完成造影Ib型内漏)。
  • 158例有1个月和3个月CTA的患者中,47例内漏持续,9例为1个月CTA未发现的新内漏,13例内漏消退;3例(1.2%)因II型内漏和动脉瘤扩张接受干预。
  • 47例仅6个月CTA的患者中,16例内漏为完成造影未发现,其中2例接受再干预(1例I型内漏,1例II型内漏)。

临床怎么用

  • 作者认为,对符合器械说明书且术中完成造影无I型内漏的择期EVAR患者,1个月监测CTA价值有限,6个月开始常规监测是安全的。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aortic aneurysm repair (EVAR) is the preferred first-line treatment for abdominal aortic aneurysms. Current postprocedure surveillance recommendations by manufacturers are a 1-month computed tomography angiography (CTA) followed by a 12-month CTA in most circumstances. The objective of this study is to determine the utility of the 1-month CTA following elective EVAR and determine if initial surveillance at 6-month CTA is appropriate. METHODS: A single-center retrospective chart review of all elective EVARs at a tertiary medical center over a 12-year period was conducted. Patients were excluded if postoperative surveillance imaging was not available. Data analysis encompassed demographics, chart review, and imaging including angiogram and cross-sectional imaging to asses for endoleaks and other findings. RESULTS: There were 363 patients who underwent elective EVAR and had available postoperative imaging during the study period. Within the 1-month follow-up, a CTA group of 316 patients was detected with 98 (31%) endoleaks. Of these, 5 (1.5%) required intervention: 1 for infolding of an iliac limb and 4 for type I endoleak which was present on completion angiogram-3 in patients treated outside of instructions for use and 1 with a type Ib endoleak on intraoperative completion imaging. In the 158 patients with 1 and 3-month CTAs, there were 47 persistent endoleaks, 9 previously undetected endoleaks not seen in 1-month CTA, and 13 resolved endoleaks. Three patients (1.2%) underwent intervention for type II endoleak and aneurysm expansion. In 47 patients with only a 6-month CTA, there were 16 endoleaks not seen on completion angiography and 2 of which were treated with reintervention-1 for a type I endoleak and 1 for a type II endoleak. CONCLUSIONS: There is limited utility to 1-month surveillance CTA in patients undergoing elective EVAR within the device instructions for use that has no evidence of type I endoleak on completion angiography. It is safe to start routine EVAR surveillance at 6 months in this patient population. This has implications when considering bundled and value-based payments in the longitudinal care of abdominal aortic aneurysm patients.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Soult MC, Cheng BT, Mansukhani NA, et al. There Is Limited Value in the One Month Post Endovascular Aortic Aneurysm Repair Surveillance Computed Tomography Scan. Ann Vasc Surg. 2018. PMID: 30253190. doi:10.1016/j.avsg.2018.08.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。